Cantor Fitzgerald Comments on Omeros Co.’s FY2024 Earnings (NASDAQ:OMER)

Omeros Co. (NASDAQ:OMER – Free Report) – Analysts at Cantor Fitzgerald lifted their FY2024 earnings per share estimates for Omeros in a research report issued to clients and investors on Monday, August 12th. Cantor Fitzgerald analyst O. Brayer now forecasts that the biopharmaceutical company will post earnings of ($2.90) per share for the year, up […]

Leave a Reply

Your email address will not be published.

Previous post Lineage Cell Therapeutics, Inc. Expected to Earn FY2024 Earnings of ($0.18) Per Share (NYSEAMERICAN:LCTX)
Next post FY2024 EPS Estimates for Celldex Therapeutics, Inc. (NASDAQ:CLDX) Boosted by Cantor Fitzgerald